First Midwest Bank Trust Division’s TherapeuticsMD TXMD Stock Holding History

First Midwest Bank Trust Division’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-356	Closed	-$19K	–	368
2020 Q1	$19K	Sell	356 -200	-36%	-$19.8K	﹤0.01%	337
2019 Q4	$67K	Hold	556	–	–	0.01%	353
2019 Q3	$101K	Hold	556	–	–	0.01%	362
2019 Q2	$72K	Hold	556	–	–	0.01%	373
2019 Q1	$135K	Hold	556	–	–	0.02%	378
2018 Q4	$106K	Hold	556	–	–	0.02%	357
2018 Q3	$182K	Hold	556	–	–	0.02%	402
2018 Q2	$173K	Hold	556	–	–	0.02%	411
2018 Q1	$135K	Hold	556	–	–	0.02%	421
2017 Q4	$168K	Hold	556	–	–	0.02%	420
2017 Q3	$147K	Hold	556	–	–	0.02%	429
2017 Q2	$147K	Hold	556	–	–	0.02%	424
2017 Q1	$200K	Hold	556	–	–	0.02%	433
2016 Q4	$160K	Hold	556	–	–	0.02%	429
2016 Q3	$189K	Hold	556	–	–	0.02%	430
2016 Q2	$236K	Hold	556	–	–	0.03%	403
2016 Q1	$178K	Buy	556 +200	+56%	+$68.2K	0.02%	395
2015 Q4	$185K	Buy	+356	New	+$131K	0.03%	362

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Midwest Bank Trust Division's TXMD Position: Q2 2020 in Review

First Midwest Bank Trust Division sold out of TherapeuticsMD (TXMD) in Q2 2020, closing a stake of 356 shares — an estimated $19K sold.

First Midwest Bank Trust Division first reported a position in TXMD in Q4 2015 and held it in 18 quarters. The position peaked at $236K in Q2 2016. 149 funds tracked by Wall St. Rank hold TXMD as of Q2 2020.

First Midwest Bank Trust Division reported no remaining TherapeuticsMD position as of Q2 2020 after selling out during the quarter.
First Midwest Bank Trust Division sold 356 TherapeuticsMD shares in Q2 2020, an estimated $19K.
First Midwest Bank Trust Division first reported a position in TherapeuticsMD in Q4 2015 and held it in 18 quarters.
First Midwest Bank Trust Division's TherapeuticsMD position peaked at $236K in Q2 2016.
149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2020.

Based on First Midwest Bank Trust Division's 13F filing for Q2 2020, filed 7 Aug 2020.